Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aim: Fluorescence detection of breast and prostate cancer cells expressing Tn-antigen, a tumor marker, with Vicia villosa lectin (VVL)-labeled nanoparticles. Materials & methods: Breast and prostate cancer cells engineered to express high levels of Tn-antigen and non-engineered controls were incubated with VVL-labeled or unlabeled red dye-doped silica-coated polystyrene nanoparticles. The binding to cells was studied with flow cytometry, confocal microscopy, and electron microscopy. Results: Flow cytometry showed that the binding of VVL-labeled nanoparticles was significantly higher to Tn-antigen-expressing cancer cells than controls. Confocal microscopy demonstrated that particles bound to the cell surface. According to the correlative light and electron microscopy the particles bound mostly as aggregates. Conclusion: VVL-labeled nanoparticles could provide a new tool for the detection of Tn-antigen-expressing breast and prostate cancer cells.

Cite

CITATION STYLE

APA

Verhassel, A., Kimani, M., Gidwani, K., Sandholm, J., Gawlitza, K., Rurack, K., & Härkönen, P. (2024). Detection of Tn-antigen in breast and prostate cancer models by VVL-labeled red dye-doped nanoparticles. Nanomedicine, 19(29), 2463–2478. https://doi.org/10.1080/17435889.2024.2405454

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free